Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Sullivan Timothy Eugene reported 13 trades in Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded May 14, 2026 · Filed May 14, 2026
On May 14, 2026, Sullivan Timothy Eugene (Chief Financial Officer) reported 13 trades in Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).
- Shares
- 212,437 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Other | 140,945 | 0 | Direct | |
| May 14, 2026 | Common Stock | Other | 71,492 | 0 | Indirect | |
| May 14, 2026 | Common Stock | Award | 41,250 | 41,250 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 41,250 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 30,620 | 30,620 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 30,620 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 29,070 | 29,070 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 29,070 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 58,140 | 58,140 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 6,872 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 11,874 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 34,447 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 58,140 | 0 | Direct |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Sullivan Timothy Eugene
- Apellis Pharmaceuticals, Inc. shareholders
- Form 4 · Sullivan Timothy Eugene · Apr 20, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026